Skip to main content
Clinical Trials/NCT07075159
NCT07075159CompletedNot Applicable

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

Janice Hernandez, MD3 sites in 1 country10 target enrollmentStarted: February 28, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
10
Locations
3
Primary Endpoint
Number of participants with wound dehiscence

Study Overview

Brief Summary

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients >18 years of age
  • follow-up at specified intervals (1 week/6 week/3 months) in an office setting
  • can give informed consent
  • no patients will be excluded on the basis of gender, ethnicity, or religious background

Exclusion Criteria

  • Patients <18 years of age or >100
  • allergy to pectin, gelatin, and sodium carboxymethylcellulose
  • adults with impaired consent capacity
  • incarcerated individuals.

Arms & Interventions

Wound Dressing

Experimental

At the conclusion of the surgical procedure, patients will receive topical wound dressing to surgical sutured periocular wounds

Intervention: Hydrocolloid Wound Dressing (Device)

Antibiotic Ointment (Control)

No Intervention

At the conclusion of the surgical procedure, patients will receive topical antibiotic ophthalmic ointment to surgical sutured periocular wounds

Outcomes

Primary Outcomes

Number of participants with wound dehiscence

Time Frame: 3 months

YES/NO type question if wound dehiscence is present after removal of the patch

Secondary Outcomes

  • Patient and Observer Scar Assessment Scale(3 months)

Investigators

Sponsor
Janice Hernandez, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Janice Hernandez, MD

Instructor

University of Kentucky

Study Sites (3)

Loading locations...

Similar Trials